リウマチ熱治療の世界市場（～2026年）

• 英文タイトル：Global Rheumatic Fever Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04513
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料はリウマチ熱治療のグローバル市場について調査・分析したレポートです。種類別（抗生物質、抗炎症薬、抗けいれん薬、その他）市場規模、用途別（病院、診療所、診断センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別リウマチ熱治療の競争状況、市場シェア
・世界のリウマチ熱治療市場：種類別市場規模 2015年-2020年（抗生物質、抗炎症薬、抗けいれん薬、その他）
・世界のリウマチ熱治療市場：種類別市場規模予測 2021年-2026年（抗生物質、抗炎症薬、抗けいれん薬、その他）
・世界のリウマチ熱治療市場：用途別市場規模 2015年-2020年（病院、診療所、診断センター、その他）
・世界のリウマチ熱治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、診断センター、その他）
・北米のリウマチ熱治療市場分析：米国、カナダ
・ヨーロッパのリウマチ熱治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのリウマチ熱治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のリウマチ熱治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのリウマチ熱治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Pfizer、Abbott Laboratories、Johnson & Johnson、Roche、Novartis、Bristol-Myers Squibb、Eli Lily、AstraZeneca、Bayer、Bausch Health
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Rheumatic fever is an autoimmune inflammatory disease which can develop as a complication of inadequately treated strep throat. Strep throat is a condition caused by group a Streptococcus bacterium. Rheumatic fever is common in the age group of 5 to 15 years, but adults can also have the condition.
Geographically, the Americas is anticipated to dominate the global rheumatic fever market owing to a well-developed healthcare sector, rising prevalence of cardiovascular diseases, and growing healthcare expenditure.

Market Analysis and Insights: Global Rheumatic Fever Treatment Market
The global Rheumatic Fever Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Rheumatic Fever Treatment Scope and Market Size
Rheumatic Fever Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rheumatic Fever Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Pfizer
Abbott Laboratories
Johnson & Johnson
Roche
Novartis
Bristol-Myers Squibb
Eli Lily
AstraZeneca
Bayer
Bausch Health

Market segment by Type, the product can be split into
Antibiotics
Anti-Inflammatory Medication
Anticonvulsant Medication
Others
Market segment by Application, split into
Hospitals
Clinics
Diagnostic Centers
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Rheumatic Fever Treatment Revenue
1.4 Market by Type
1.4.1 Global Rheumatic Fever Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antibiotics
1.4.3 Anti-Inflammatory Medication
1.4.4 Anticonvulsant Medication
1.4.5 Others
1.5 Market by Application
1.5.1 Global Rheumatic Fever Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Diagnostic Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Rheumatic Fever Treatment Market Perspective (2015-2026)
2.2 Global Rheumatic Fever Treatment Growth Trends by Regions
2.2.1 Rheumatic Fever Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Rheumatic Fever Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Rheumatic Fever Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Rheumatic Fever Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Rheumatic Fever Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Rheumatic Fever Treatment Players by Market Size
3.1.1 Global Top Rheumatic Fever Treatment Players by Revenue (2015-2020)
3.1.2 Global Rheumatic Fever Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Rheumatic Fever Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Rheumatic Fever Treatment Market Concentration Ratio
3.2.1 Global Rheumatic Fever Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Rheumatic Fever Treatment Revenue in 2019
3.3 Rheumatic Fever Treatment Key Players Head office and Area Served
3.4 Key Players Rheumatic Fever Treatment Product Solution and Service
3.5 Date of Enter into Rheumatic Fever Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Rheumatic Fever Treatment Historic Market Size by Type (2015-2020)
4.2 Global Rheumatic Fever Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Rheumatic Fever Treatment Market Size by Application (2015-2020)
5.2 Global Rheumatic Fever Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Rheumatic Fever Treatment Market Size (2015-2020)
6.2 Rheumatic Fever Treatment Key Players in North America (2019-2020)
6.3 North America Rheumatic Fever Treatment Market Size by Type (2015-2020)
6.4 North America Rheumatic Fever Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Rheumatic Fever Treatment Market Size (2015-2020)
7.2 Rheumatic Fever Treatment Key Players in Europe (2019-2020)
7.3 Europe Rheumatic Fever Treatment Market Size by Type (2015-2020)
7.4 Europe Rheumatic Fever Treatment Market Size by Application (2015-2020)

8 China
8.1 China Rheumatic Fever Treatment Market Size (2015-2020)
8.2 Rheumatic Fever Treatment Key Players in China (2019-2020)
8.3 China Rheumatic Fever Treatment Market Size by Type (2015-2020)
8.4 China Rheumatic Fever Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Rheumatic Fever Treatment Market Size (2015-2020)
9.2 Rheumatic Fever Treatment Key Players in Japan (2019-2020)
9.3 Japan Rheumatic Fever Treatment Market Size by Type (2015-2020)
9.4 Japan Rheumatic Fever Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Rheumatic Fever Treatment Market Size (2015-2020)
10.2 Rheumatic Fever Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Rheumatic Fever Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Rheumatic Fever Treatment Market Size by Application (2015-2020)

11 India
11.1 India Rheumatic Fever Treatment Market Size (2015-2020)
11.2 Rheumatic Fever Treatment Key Players in India (2019-2020)
11.3 India Rheumatic Fever Treatment Market Size by Type (2015-2020)
11.4 India Rheumatic Fever Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Rheumatic Fever Treatment Market Size (2015-2020)
12.2 Rheumatic Fever Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Rheumatic Fever Treatment Market Size by Type (2015-2020)
12.4 Central & South America Rheumatic Fever Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Rheumatic Fever Treatment Introduction
13.1.4 Pfizer Revenue in Rheumatic Fever Treatment Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Details
13.2.2 Abbott Laboratories Business Overview
13.2.3 Abbott Laboratories Rheumatic Fever Treatment Introduction
13.2.4 Abbott Laboratories Revenue in Rheumatic Fever Treatment Business (2015-2020)
13.2.5 Abbott Laboratories Recent Development
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Details
13.3.2 Johnson & Johnson Business Overview
13.3.3 Johnson & Johnson Rheumatic Fever Treatment Introduction
13.3.4 Johnson & Johnson Revenue in Rheumatic Fever Treatment Business (2015-2020)
13.3.5 Johnson & Johnson Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview
13.4.3 Roche Rheumatic Fever Treatment Introduction
13.4.4 Roche Revenue in Rheumatic Fever Treatment Business (2015-2020)
13.4.5 Roche Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Rheumatic Fever Treatment Introduction
13.5.4 Novartis Revenue in Rheumatic Fever Treatment Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Bristol-Myers Squibb
13.6.1 Bristol-Myers Squibb Company Details
13.6.2 Bristol-Myers Squibb Business Overview
13.6.3 Bristol-Myers Squibb Rheumatic Fever Treatment Introduction
13.6.4 Bristol-Myers Squibb Revenue in Rheumatic Fever Treatment Business (2015-2020)
13.6.5 Bristol-Myers Squibb Recent Development
13.7 Eli Lily
13.7.1 Eli Lily Company Details
13.7.2 Eli Lily Business Overview
13.7.3 Eli Lily Rheumatic Fever Treatment Introduction
13.7.4 Eli Lily Revenue in Rheumatic Fever Treatment Business (2015-2020)
13.7.5 Eli Lily Recent Development
13.8 AstraZeneca
13.8.1 AstraZeneca Company Details
13.8.2 AstraZeneca Business Overview
13.8.3 AstraZeneca Rheumatic Fever Treatment Introduction
13.8.4 AstraZeneca Revenue in Rheumatic Fever Treatment Business (2015-2020)
13.8.5 AstraZeneca Recent Development
13.9 Bayer
13.9.1 Bayer Company Details
13.9.2 Bayer Business Overview
13.9.3 Bayer Rheumatic Fever Treatment Introduction
13.9.4 Bayer Revenue in Rheumatic Fever Treatment Business (2015-2020)
13.9.5 Bayer Recent Development
13.10 Bausch Health
13.10.1 Bausch Health Company Details
13.10.2 Bausch Health Business Overview
13.10.3 Bausch Health Rheumatic Fever Treatment Introduction
13.10.4 Bausch Health Revenue in Rheumatic Fever Treatment Business (2015-2020)
13.10.5 Bausch Health Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Rheumatic Fever Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Rheumatic Fever Treatment Revenue
Table 3. Ranking of Global Top Rheumatic Fever Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Rheumatic Fever Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antibiotics
Table 6. Key Players of Anti-Inflammatory Medication
Table 7. Key Players of Anticonvulsant Medication
Table 8. Key Players of Others
Table 9. Global Rheumatic Fever Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Rheumatic Fever Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Rheumatic Fever Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Rheumatic Fever Treatment Market Share by Regions (2015-2020)
Table 13. Global Rheumatic Fever Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Rheumatic Fever Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Rheumatic Fever Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Rheumatic Fever Treatment Players
Table 20. Global Rheumatic Fever Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Rheumatic Fever Treatment Market Share by Players (2015-2020)
Table 22. Global Top Rheumatic Fever Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatic Fever Treatment as of 2019)
Table 23. Global Rheumatic Fever Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Rheumatic Fever Treatment Product Solution and Service
Table 26. Date of Enter into Rheumatic Fever Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Rheumatic Fever Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Rheumatic Fever Treatment Market Size Share by Type (2015-2020)
Table 30. Global Rheumatic Fever Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Rheumatic Fever Treatment Market Size Share by Application (2015-2020)
Table 32. Global Rheumatic Fever Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Rheumatic Fever Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Rheumatic Fever Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Rheumatic Fever Treatment Market Share (2019-2020)
Table 36. North America Rheumatic Fever Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Rheumatic Fever Treatment Market Share by Type (2015-2020)
Table 38. North America Rheumatic Fever Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Rheumatic Fever Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Rheumatic Fever Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Rheumatic Fever Treatment Market Share (2019-2020)
Table 42. Europe Rheumatic Fever Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Rheumatic Fever Treatment Market Share by Type (2015-2020)
Table 44. Europe Rheumatic Fever Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Rheumatic Fever Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Rheumatic Fever Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Rheumatic Fever Treatment Market Share (2019-2020)
Table 48. China Rheumatic Fever Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Rheumatic Fever Treatment Market Share by Type (2015-2020)
Table 50. China Rheumatic Fever Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Rheumatic Fever Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Rheumatic Fever Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Rheumatic Fever Treatment Market Share (2019-2020)
Table 54. Japan Rheumatic Fever Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Rheumatic Fever Treatment Market Share by Type (2015-2020)
Table 56. Japan Rheumatic Fever Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Rheumatic Fever Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Rheumatic Fever Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Rheumatic Fever Treatment Market Share (2019-2020)
Table 60. Southeast Asia Rheumatic Fever Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Rheumatic Fever Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Rheumatic Fever Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Rheumatic Fever Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Rheumatic Fever Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Rheumatic Fever Treatment Market Share (2019-2020)
Table 66. India Rheumatic Fever Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Rheumatic Fever Treatment Market Share by Type (2015-2020)
Table 68. India Rheumatic Fever Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Rheumatic Fever Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Rheumatic Fever Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Rheumatic Fever Treatment Market Share (2019-2020)
Table 72. Central & South America Rheumatic Fever Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Rheumatic Fever Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Rheumatic Fever Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Rheumatic Fever Treatment Market Share by Application (2015-2020)
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Product
Table 79. Pfizer Revenue in Rheumatic Fever Treatment Business (2015-2020) (Million US$)
Table 80. Pfizer Recent Development
Table 81. Abbott Laboratories Company Details
Table 82. Abbott Laboratories Business Overview
Table 83. Abbott Laboratories Product
Table 84. Abbott Laboratories Revenue in Rheumatic Fever Treatment Business (2015-2020) (Million US$)
Table 85. Abbott Laboratories Recent Development
Table 86. Johnson & Johnson Company Details
Table 87. Johnson & Johnson Business Overview
Table 88. Johnson & Johnson Product
Table 89. Johnson & Johnson Revenue in Rheumatic Fever Treatment Business (2015-2020) (Million US$)
Table 90. Johnson & Johnson Recent Development
Table 91. Roche Company Details
Table 92. Roche Business Overview
Table 93. Roche Product
Table 94. Roche Revenue in Rheumatic Fever Treatment Business (2015-2020) (Million US$)
Table 95. Roche Recent Development
Table 96. Novartis Company Details
Table 97. Novartis Business Overview
Table 98. Novartis Product
Table 99. Novartis Revenue in Rheumatic Fever Treatment Business (2015-2020) (Million US$)
Table 100. Novartis Recent Development
Table 101. Bristol-Myers Squibb Company Details
Table 102. Bristol-Myers Squibb Business Overview
Table 103. Bristol-Myers Squibb Product
Table 104. Bristol-Myers Squibb Revenue in Rheumatic Fever Treatment Business (2015-2020) (Million US$)
Table 105. Bristol-Myers Squibb Recent Development
Table 106. Eli Lily Company Details
Table 107. Eli Lily Business Overview
Table 108. Eli Lily Product
Table 109. Eli Lily Revenue in Rheumatic Fever Treatment Business (2015-2020) (Million US$)
Table 110. Eli Lily Recent Development
Table 111. AstraZeneca Business Overview
Table 112. AstraZeneca Product
Table 113. AstraZeneca Company Details
Table 114. AstraZeneca Revenue in Rheumatic Fever Treatment Business (2015-2020) (Million US$)
Table 115. AstraZeneca Recent Development
Table 116. Bayer Company Details
Table 117. Bayer Business Overview
Table 118. Bayer Product
Table 119. Bayer Revenue in Rheumatic Fever Treatment Business (2015-2020) (Million US$)
Table 120. Bayer Recent Development
Table 121. Bausch Health Company Details
Table 122. Bausch Health Business Overview
Table 123. Bausch Health Product
Table 124. Bausch Health Revenue in Rheumatic Fever Treatment Business (2015-2020) (Million US$)
Table 125. Bausch Health Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rheumatic Fever Treatment Market Share by Type: 2020 VS 2026
Figure 2. Antibiotics Features
Figure 3. Anti-Inflammatory Medication Features
Figure 4. Anticonvulsant Medication Features
Figure 5. Others Features
Figure 6. Global Rheumatic Fever Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Diagnostic Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Rheumatic Fever Treatment Report Years Considered
Figure 12. Global Rheumatic Fever Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Rheumatic Fever Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Rheumatic Fever Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Rheumatic Fever Treatment Market Share by Players in 2019
Figure 17. Global Top Rheumatic Fever Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rheumatic Fever Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Rheumatic Fever Treatment Revenue in 2019
Figure 19. North America Rheumatic Fever Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Rheumatic Fever Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Rheumatic Fever Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Rheumatic Fever Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Rheumatic Fever Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Rheumatic Fever Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Rheumatic Fever Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed

以下、関連資料のご紹介

痛み・発熱緩和薬の世界市場（～2026年）

Global Pain and Fever Relief Drugs Market Insights and Forecast to 2026
MRC2-11QY08666 2020年11月25日 110Pages
当調査資料は痛み・発熱緩和薬のグローバル市場について調査・分析したレポートです。種類別（アスピリン、パラセタモール、ナプロキセン、イブプロフェン、ジクロフェン酸、メタミゾールナトリウム）市場規模、用途別（病院、クリニック、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フラ...

間欠的発熱症候群の世界市場（～2026年）

Global Periodic Fever Syndrome Market Size, Status and Forecast 2020-2026
MRC2-11QY04216 2020年11月20日 98Pages
当調査資料は間欠的発熱症候群のグローバル市場について調査・分析したレポートです。種類別（高IGE D症候群、家族性地中海熱症候群、TNF受容体関連周期症候群、クリオピリン関連周期症候群、その他）市場規模、用途別（病院、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギ...

リウマチ性心臓病の世界市場（～2026年）

Global Rheumatic Heart Disease Market Size, Status and Forecast 2020-2026
MRC2-11QY04514 2020年11月20日 127Pages
当調査資料はリウマチ性心臓病のグローバル市場について調査・分析したレポートです。種類別（弁、心筋炎、心膜炎）市場規模、用途別（病院、診断センター、研究センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラ...

Q熱の世界市場（～2026年）

Global Q Fever Market Size, Status and Forecast 2020-2026
MRC2-11QY04425 2020年11月20日 95Pages
当調査資料はQ熱のグローバル市場について調査・分析したレポートです。種類別（急性Q熱、慢性Q熱）市場規模、用途別（病院・診療所、診断センター、外科センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア...

人獣共通感染症治療の世界市場（～2026年）

Global Zoonotic Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY05134 2020年11月20日 93Pages
当調査資料は人獣共通感染症治療のグローバル市場について調査・分析したレポートです。種類別（ウイルス性肝炎、狂犬病、回帰熱、結核、マラリア）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イン...

マールブルグ出血熱治療薬の世界市場（～2026年）

Global Marburg Hemorrhagic Fever Drug Market Insights and Forecast to 2026
MRC2-11QY07470 2020年11月20日 112Pages
当調査資料はマールブルグ出血熱治療薬のグローバル市場について調査・分析したレポートです。種類別（マールブルグワクチン、AVI-7288、TKM-マールブルグ、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロ...

チクングニア熱治療薬の世界市場（～2026年）

Global Chikungunya Fever Drugs Market Insights and Forecast to 2026
MRC2-11QY00189 2020年11月20日 116Pages
当調査資料はチクングニア熱治療薬のグローバル市場について調査・分析したレポートです。種類別（チクングニア熱ワクチン、モノクローナル抗体、ポリ硫酸ペントサンナトリウム、合成ペプチド、その他）市場規模、用途別（クリニック、研究機関、病院）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス...

クラッベ病治療の世界市場（～2026年）

Global Krabbe Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12467 2020年11月25日 94Pages
当調査資料はクラッベ病治療のグローバル市場について調査・分析したレポートです。種類別（抗けいれん薬、筋弛緩薬、造血幹細胞移植、その他）市場規模、用途別（病院、ASC）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...

アレルギー性鼻炎治療の世界市場（～2026年）

Global Allergic Rhinitis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY13652 2020年11月30日 91Pages
当調査資料はアレルギー性鼻炎治療のグローバル市場について調査・分析したレポートです。種類別（抗ヒスタミン薬、鼻腔内コルチコステロイド、免疫療法、充血除去薬、その他）市場規模、用途別（季節性アレルギー性鼻炎、通年性アレルギー性鼻炎）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イ...

結節性痒疹治療の世界市場（～2026年）

Global Prurigo Nodularis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04403 2020年11月20日 97Pages
当調査資料は結節性痒疹治療のグローバル市場について調査・分析したレポートです。種類別（カプサイシンクリーム、抗ヒスタミン薬、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国...

Q熱の世界市場（～2026年） Q fever is a mild disease with flu-like symptoms. Many patients have no symptoms at all while in some cases; the infection can reoccur/resurface years later. The chronic Q fever is a more deadly form of Q fever which may damage heart, liver, brain, lungs and can cause diabetes in some cases. The Ame…
間欠的発熱症候群の世界市場（～2026年） Periodic fever syndrome are a set of disorders characterized by recurrent episodes of systemic and organ-specific inflammation. The syndromes are diverse, but tend to cause episodes of fever, joint pains, skin rashes, abdominal pains and may lead to chronic complications such as amyloidosis. Market …
リウマチ性心臓病の世界市場（～2026年） Rheumatic heart disease is a complication ofrheumatic fever in which the heart valves are damaged. Increasing environmental pollution resulting in higher prevalence of viral and fungal infection is one of the major factor motivating the growth of this market. In addition, increasing healthcare expen…
マールブルグ出血熱治療薬の世界市場（～2026年） Market Analysis and Insights: Global Marburg Hemorrhagic Fever Drug Market The global Marburg Hemorrhagic Fever Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Marburg Hemorrhagic Fever Drug Scope and Market Size …
痛み・発熱緩和薬の世界市場（～2026年） The demand for Pain and Fever Relief Drugs will continue to grow in the next few years. Market Analysis and Insights: Global Pain and Fever Relief Drugs Market The global Pain and Fever Relief Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of X…